STUDY QUESTION: Is there perfusion to the fallopian tubes in ex-vivo and in-vivo uteri at the time of total laparoscopic hysterectomy (TLH), as observed using laser angiography with indocyanine green (ICG)?
Introduction
Uterine transplantation is emerging as a potential therapeutic option for women with absolute uterine factor infertility, with~30 cases completed to date worldwide (Brannstrom et al., 2017) . However, the surgical procedure is still considered experimental, and may be accompanied by surgical complications and graft failure. Current investigations aim to appropriately select uterine graft donors, improve the surgical transplantation procedure, and prevent post-operative complications (Jones et al., 2016; Brannstrom et al., 2017; Flyckt et al., 2018) .
During donor hysterectomy, the fallopian tubes are typically transected (Ejzenberg et al., 2016) . Recipients undergo IVF to achieve pregnancy. In addition to potential fetal and maternal complications associated with IVF, the procedure is generally expensive throughout the world, ranging from $1000 to $12 000 per cycle (Teoh and Maheshwari, 2014) . This can cause a financial and an emotional burden on the recipients (Zaidi, 2017) . Prior animal studies have evaluated fertility after transplantation of the uterus with the tubes and ovaries as well as of the tubes and ovaries alone (Scott et al., 1987; Enskog et al., 2010; Wranning et al., 2010; Johannesson et al., 2012) . One study evaluated viability after transplantation of the uterus with attached fallopian tubes in animals and subsequently in a human subject; however, the human transplanted uterus was removed after 99 days due to thrombosis of the uterine vessels and resulting tissue infarction. The fallopian tubes appeared viable upon final inspection (Fageeh et al., 2002) . If feasible, uterine-tubal transplantation may allow for spontaneous conception in recipient women. In this study, we aim to assess the vascular perfusion to the fallopian tubes by the utero-ovarian vessels in hysterectomy specimens.
Laser angiography with indocyanine green (ICG) (Akorn Inc., Lake Forest, IL, USA) has been used to assess real-time tissue perfusion in various surgical fields (Balacumaraswami and Taggart, 2007; Pacheco et al., 2013; Foppa et al., 2014; Munabi et al., 2014; Colvard et al., 2016; McCabe et al., 2017; Partington et al., 2017; Rother et al., 2017; Sassalos et al., 2017) . A recent pilot study suggests that laser angiography may be used to evaluate for the vaginal cuff perfusion after a total laparoscopic hysterectomy (TLH) (Beran et al., 2017b) . Another study demonstrated successful use of laser angiography to predict uterine fundal perfusion after radical trachelectomy (Escobar et al., 2016) . Blood flow was evaluated by comparing the cerebral blood flow index, measured by dividing maximum ICG absorption over time, to mean blood flow velocity, measured by Doppler ultrasound, in mice undergoing hemorrhagic shock. The two methods were found to be significantly correlated (Bein et al., 2006) . When compared to laser speckle contrast imaging, ICG angiography was determined to be a good method for capturing volumes of blood at any given time-point (Towle et al., 2012) .
The objectives of this study are to use ICG angiography to (i) evaluate perfusion of the fallopian tubes using the utero-ovarian vessels in ex-vivo uteri after TLH and (ii) evaluate perfusion of the fallopian tubes from the utero-ovarian vessels in vivo after transection of the mesosalpinx and uterine vessels during TLH.
Materials and Methods

Study approval, subject recruitment and enrollment
The ex-vivo protocol was deemed exempt by the Institutional Review Board at Cleveland Clinic Florida. Consent was not deemed necessary for this portion of the study; however, agreement to participation was obtained from patients prior to proceeding. Five women aged 18 or older who were scheduled to undergo TLH or robotic-assisted TLH (RA-TLH) with bilateral salpingectomy for benign indications were approached during their pre-operative visit and provided with an information sheet regarding the study. The in-vivo portion of the study was approved by the Institutional Review Board at Cleveland Clinic Florida (FLA 17-008). Ten women aged 18 or older scheduled to undergo laparoscopic or roboticassisted hysterectomy with bilateral salpingectomy for benign indications were approached at their pre-operative visit in the office and consented to participate in the study.
Women with gynecologic cancer, previously diagnosed tubal occlusion, prior tubal ligation, prior salpingectomy, congenital absence of adnexa, obstructive myomas on pre-operative imaging, uteri measuring >13 cm longitudinally on pre-operative imaging, or poor vaginal access were excluded from the study. Non-English speaking patients and pregnant patients were also excluded. Women with hypersensitivity or allergy to Iodine or ICG were excluded from the in-vivo protocol. All women who met the inclusion criteria were approached regarding study participation sequentially, initially recruiting for the ex-vivo protocol followed by the invivo protocol.
Ex-vivo protocol
After each participant was intubated and prepared for surgery, the hysterectomy proceeded using an ultrasonic dissection device (Sonicision™; Medtronic-Covidien, Minneapolis, MN, USA). The mesosalpinges were transected followed by the round ligaments. Two large surgical clips (LIGACLIP ® Multi-Clip Appliers; Ethicon, Inc., Somerville, NJ, USA) were placed on the utero-ovarian vessels proximal to the ovaries. The uteroovarian vessels were then transected. The anterior and posterior leaves of the broad ligaments were divided. The bladder was mobilized caudally. The uterine vessels were skeletonized, coagulated with bipolar energy (fenestrated grasping forceps; Richard Wolf Co., Vernon Hills, IL, USA), and transected. The colpotomy was completed and the uterus was removed vaginally. No perforating instruments were used during the surgeries. The uterus with the attached fallopian tubes was passed off the surgical field to the research investigator. The surgical clips were now removed from the utero-ovarian vessels and the uterus was placed flat on a table with the fallopian tubes extended bilaterally. The specimen was not flushed with heparin. The utero-ovarian arteries were identified and measured. The longer of the two uteroovarian arteries was cannulated using a non-traumatic 0.45 mm nitinol guidewire followed by a 4 Fr catheter (B. Braun Interventional Systems, Inc., Bethlehem, PA, USA), which was advanced over the wire and secured in place using a 0-Silk suture tie. The guidewire was then removed. The catheter was attached to an intravenous line that was flushed with 0.9% normal saline solution. Next, 10 ml of sterile water solvent was mixed with 25 mg of ICG powder and 3 ml of the ICG solution was mixed with 50 ml of 0.9% normal saline solution. This solution was attached to the intravenous line. The room lights were dimmed and the ICG solution was slowly injected at a rate of 5 ml per minute into the utero-ovarian artery while imaging with laser angiography (SPY Elite system; Novadaq Technologies, Toronto, Canada). The solution was allowed to drain from the uteroovarian vein. Video and still images were captured. Video and images were all de-identified, for this and all portions of the study. Quantitative assessment was obtained by using the 'contour' feature on the laser angiography imaging system. The contour feature overlays lines on the image that represent lines of isofluorescence (i.e. every point on the contour has equal fluorescence). The contour line was set at 20% for all specimens, which signifies that every point on the line corresponded to 20% of the fluorescence beneath the '100% reference marker'. The 100% reference marker was placed on the fundus of the uterus in a location with maximum fluorescence. Other markers were placed on the bilateral fimbria of the fallopian tubes and the cervix (Fig. 1A) . The uterus was sent for permanent pathologic evaluation after the study procedure was complete.
The maximum fluorescence intensity values at each of the chosen markers and the time to cannulation were recorded in a spreadsheet (Microsoft Excel 2015 for Mac, Version 15.33; Microsoft Corporation, Redmond, WA). No identifying information was collected. Each trial was identified by a number.
In-vivo protocol
After each participant was intubated and prepared for surgery, a uterine manipulator was placed (VCARE ® ; Conmed Co., Utica, NY, USA).
Attention was turned to the abdomen where an umbilical 12 mm trocar was placed and the abdomen was insufflated with CO 2 gas to a final pressure of 15 mm Hg. The laser angiography camera was inserted and three other trocars were placed under direct visualization as per surgeon preference. The PINPOINT (Novadaq Technologies, Toronto, Canada) laser angiography system was utilized in laparoscopic procedures and the Firefly (Intuitive Surgical, Sunnyvale, CA, USA) was utilized in robotic-assisted laparoscopic procedures. After the fallopian tubes were in view, the anesthesiologist administered 2 ml of ICG solution (2.5 mg/ml) followed by a 10 ml crystalloid flush. Still images were captured of the normal 'pre-procedure' fallopian tubes using laser angiography (Fig. 1B) . All images included the fallopian tubes from the isthmus to the fimbria. The mesalpinges were transected using the Sonicision™ followed by the round ligaments. The utero-ovarian vessels were kept intact bilaterally. The anterior and posterior leaves of the broad ligament were divided. The bladder was mobilized caudally. The uterine vessels were skeletonized, coagulated with bipolar fenestrated grasping forceps, and transected. The procedure was paused at this step in the first five cases (partial protocol). A colpotomy was performed in the last five cases (complete protocol). The partial protocol was performed to ensure that the surgical procedure was feasible amongst the research investigators. Once all surgeons were able to perform the procedure, the complete protocol was performed for the last five cases to more closely simulate the vascular supply in a transplanted uterus, including the lack of perfusion or drainage from collateral Figure 1 Sample SPY Elite System ex-vivo image demonstrating perfusion of the uterus as well as the fallopian tubes (A) and sample NOVADAQ PINPOINT in-vivo images (B-D). Tubal perfusion was demonstrated before the surgical procedure was initiated, after indocyanine green (ICG) administration, 'pre-procedure' (B). The tubes were imaged after the surgical protocol was completed, prior to administration of a second dosage of ICG, 'pre-ICG' (C), and after administration of a second dosage of ICG, 'post-ICG' (D).
vasculature from the lower uterine vessels. No perforating instruments were used during the surgeries.
Laser angiography was then activated. 'Pre-ICG' images were captured (Fig. 1C) . The anesthesiologist administered another 2 ml of ICG solution (2.5 mg/ml) followed by a 10 ml crystalloid flush. 'Post-ICG' images were captured one minute after the appearance of ICG in the uterus (Fig. 1D) . The laser angiography was shut off and the hysterectomy procedure was completed as per usual.
Upon completion of the in-vivo protocol data collection, the preprocedure, pre-ICG and post-ICG images were assigned identification numbers using a random number generator (GraphPad Software, La Jolla, CA, USA). The master list of these identification numbers was stored in a locked spreadsheet and was not accessible to any of the reviewers. Authors S.F., P.F.P., K.A.S. and M.L.S. were provided with the images for blinded review. An image processing software (ImageJ; National Institutes of Health, Bethesda, MD, USA) was used to review the images. The length of each fallopian tube was measured in pixels using the quantitative segmented line feature in ImageJ. As deemed by each reviewer, the fluorescent portion of each fallopian tube was also measured. Each reviewer compiled his/her measurements in a spreadsheet. The fluorescence intensity ratio (length of fluorescent fallopian tube/total length of fallopian tube) was calculated for each fallopian tube reviewed.
Statistical analysis
The electronic medical record was used to collect demographic information including age, race, BMI, parity, indication for surgery, prior uterine surgery breaching the myometrium, final pathology and uterine weight. Normally distributed data were reported with means and standard deviations. Non-normally distributed data were reported with medians and interquartile ranges.
A paired Student's t test was used to compare the pre-procedure and post-ICG fluorescence intensity ratios for the partial and complete in-vivo protocols. The intraclass correlation estimates and their 95% CI were calculated based on a mean-rating (κ = 3), consistency, two-way mixedeffects model. All statistical analysis was performed using SAS version 9.3 (SAS Institute Inc., Cary, NC, USA).
Results
Demographic characteristics of all participants are presented in Table I by protocol. The mean age of all participants was 42.7 ± 7.7 years, with a range of 32-59 years. There was an equal number of African American, Hispanic and Caucasian participants. The mean BMI was 28.01 ± 6.25. The majority of the participants were parous (n = 11, 73%), had not had prior uterine surgery (n = 13, 87%), and were undergoing hysterectomy for abnormal uterine bleeding (n = 10, 67%). One participant was post-menopausal (case #3) and underwent surgery for persistent post-menopausal bleeding. The mean uterine weight was 173.9 ± 118.1 g. No participants had prior uterine artery embolization, endometrial ablation or radiofrequency ablation of fibroids.
The results of the ex-vivo protocol are presented in Table II . The median (interquartile range) time from specimen removal to uteroovarian artery cannulation was 28 min (18-29 min). The first case took 50 min, which was the longest time to cannulation. Relative to the uterine fundus, the median (interquartile range) fluorescence was 47% (42-70%) at the fimbria of the ipsilateral fallopian tube, 2.4% (1.1-29%) at the fimbria of the contralateral fallopian tube, and 7.9% (6.9-25%) at the cervix.
The fluorescence intensity ratios of the fallopian tubes in the in-vivo protocol are presented in Table III . The intraclass correlation coefficient was 0.99 between the four raters. The mean pre-procedure fluorescence intensity ratio was 0.99 ± 0.45 for both protocols, 0.98 ± 0.06 for the partial protocol and 1.00 ± 0 for the complete protocol. The mean pre-ICG fluorescence intensity ratio was 0.11 ± 0.19 for both protocols, 0.12 ± 0.21 for the partial protocol and 0.11 ± 0.18 for the complete protocol. The mean post-ICG fluorescence intensity ratio was 0.70 ± 0.36 for both protocols, 0.61 ± 0.40 for the partial protocol and 0.78 ± 0.30 for the complete protocol. The mean difference (MD) between the pre-procedure and the post-ICG fluorescence intensity ratios was 0.29 (95% CI: 0.21-0.37, P < 0.0001) when both protocols were assessed together. For the partial protocol, the MD was 0.37 (95% CI: 0.23-0.50, P < 0.0001). For the complete protocol, the MD was 0.22 (95% CI: 0.12-0.31, P < 0.0001). Of note, during two of the hysterectomies, the utero-ovarian vessels were coagulated due to bleeding prior to administration of the second dose of ICG.
Discussion
We have shown that the tubes may have perfusion by the uteroovarian vasculature alone, potentially allowing for future studies regarding tubal viability in recipients of uterine transplants. Many research questions remain regarding uterine transplantation, including optimal assessment of the uterine vasculature in donors preoperatively, which vessels to procure and to anastomose, and which mode to use for uterine procurement (Brannstrom et al., 2017) . The length of the initial graft donor surgical procedures in the Swedish series ranged from 10 to 13 h due to extensive dissection of the bilateral uterine veins and arteries (Brannstrom et al., 2014 (Brannstrom et al., , 2015 . End-to-side anastomoses to the external iliac vessels were performed in the recipients to perfuse and drain the uterus. More recently, several trials have used the uterine artery for perfusion and the utero-ovarian vein for drainage, as was demonstrated in an ex-vivo perfusion study using hysterectomy specimens (Arnolds et al., 2016; Testa et al., 2017; Wei et al., 2017) . In doing so, the length of surgery was reduced to 6-9 h and the complex uterine vein dissection from the nearby ureter was avoided. Additionally, minimally invasive approaches have now been introduced (Wei et al., 2017; Puntambekar et al., 2018) .
Our team of investigators has assessed the use of the utero-ovarian vein and the utero-ovarian artery to drain and perfuse the transplanted uterus, respectively (Shockley et al., 2017; Beran et al., 2017a) . Preliminary findings from studies in the Papio hamadryas baboons demonstrated livebirths after ligation of the uterine vessels without reanastomosis, leaving the utero-ovarian vessels and the fallopian tubes intact, allowing for spontaneous conception. This begs the questions: can the utero-ovarian vessels be utilized for uterine perfusion and drainage to avoid harvesting the uterine vessels and decrease donor morbidity? Can the donor fallopian tubes remain attached to the uterus to allow for spontaneous conception in the recipient?
In this study, we evaluated perfusion of the fallopian tubes as an initial step toward possible use of the fallopian tubes in uterine transplantation protocols. We demonstrated perfusion to the fallopian tubes both ex vivo and in vivo. In the ex-vivo protocol, the fimbria of the ipsilateral fallopian tube had a 47% median relative fluorescence as compared to the contralateral fallopian tube, which only had 2.4% median relative fluorescence. In practice, both sides of the utero- 
Demographic characteristic Protocol
Ex-vivo In-vivo, partial In-vivo, complete (n = 5) (n = 5) (n = 5)
Age, years (mean ± standard deviation) 46.8 ± 9.2 40 ± 5 4 1 ± 7.9
Race (n (%))
BMI (mean ± standard deviation) 25.9 ± 5.8 29.5 ± 6.6 28.6 ± 7.1
Indication for surgery (n (%))
Prior uterine surgery (n (%)) 1 (20%) 1 (20%) 0 (0%)
Final pathology (n (%))
Uterine weight, g (mean ± standard deviation) 115 ± 68.4 278 ± 151.4 128.8 ± 27.8 AUB, abnormal uterine bleeding; A, adenomyosis; L, leiomyoma; O, ovulatory; BS, bilateral salpingectomy; BSO, bilateral salpingo-oophorectomy; CIN, cervical intraepithelial neoplasia; PMB, post-menopausal bleeding; RA-TLH, robotic-assisted total laparoscopic hysterectomy; TLH, total laparoscopic hysterectomy.
ovarian vessels would undergo reanastomosis, likely leading to perfusion of both fallopian tubes. In the in-vivo protocol, the post-ICG fluorescence intensity ratios were 0.61 ± 0.40 (~61% of the tubal length) for the partial protocol, and 0.78 ± 0.30 (~78% of the tubal length) for the complete protocol, with a mean difference of 0.37 (95% CI: 0.23-0.50, P < 0.0001) and 0.22 (95% CI: 0.12-0.31, P < 0.0001), respectively. Most (60%, 12 of 20 individual tubes) fallopian tubes had >0.75 fluorescence intensity ratios, or >75% tubal length fluorescence. The increase in fluorescence intensity between the partial protocol and the complete protocol may be due to improved study surgical techniques and improved understanding of the vasculature of the fallopian tube as the study progressed. It is well known that perfusion and drainage of the fallopian tubes occurs via the uterine and ovarian vessels, from which tubal branches arise. This arcade of vessels in the mesosalpinx is necessary to ensure proper tubal function. In our study, the mesosalpinx was disrupted fully in the ex-vivo protocol and only to the level of the utero-ovarian vessels in the in-vivo protocol, potentially accounting for the observed difference in fluorescence intensities. As the study progressed, we noted differences in the location of the utero-ovarian vessels amongst participants. In some women, the utero-ovarian vessels appeared to arise from the ovarian vessels at the lateral aspect of the ovary (Fig. 2A) ; while in others, this bifurcation occurred more medially (Fig. 2B) . The utero-ovarian ligament was always separate from the utero-ovarian vessels; in fact, the utero-ovarian ligament did contain large vessels.
With regard to uterine transplantation, longer utero-ovarian vessels would likely result in accessible and technically easier re-anastomoses. We observed that the presence of long utero-ovarian ligaments may also signify long utero-ovarian vessels, as depicted in Fig. 3 . Imaging may be used to detect the length of the utero-ovarian vasculature for use in future studies. In fact, several authors have suggested the use of pre-operative imaging for donor selection. In one uterine transplantation trial, Brucker et al. (2018) aborted the donor hysterectomy due to stenotic uterine vasculature. Pre-operatively, commuted tomography (CT) imaging and magnetic resonance angiography (MRA) demonstrated calcifications in the proximal internal iliac artery, which may have been a suggestion for the stenosis found intra-operatively. Testa et al. (2017) proposed MRI with venous phase in uterine donor candidates.
The uteri included in our study had pathology which would not be considered appropriate for donor selection, including fibroids, adenomyosis and endometrial polyps. Such pathology could have affected the overall uterine and tubal vasculature. The lack of randomization and a control group are also weaknesses of our study. Much of our trial was based on uterine transplantation protocols currently in formulation, particularly usage of the utero-ovarian vessels alone. Bilateral utero-ovarian vessels coagulated during surgery due to bleeding
Unlike prior trials evaluating the functionality of the fallopian tubes after uterine-ovarian-tubal transplantation in non-human primates , we propose uterine-tubal transplantation in animal models using utero-ovarian vessel reanastomosis to evaluate tubal functionality (Shockley et al., 2017) . Fageeh et al. reported such an animal study, wherein the uterus and attached fallopian tubes was transplanted in baboons and goats. Tubal viability was observed during subsequent exploratory laparotomy 6-12 weeks after the initial transplantation procedure (Fageeh et al., 2002) . However, the tubal functionality was not assessed or reported, as there was no mention of Figure 2 The relationship between the utero-ovarian vessels, the ovary and the tube. The utero-ovarian vessels may arise from the ovarian vessels close to the lateral aspect of the ovary (A) or more medially (B). The star is placed over the utero-ovarian vessels. menstrual function or fertility post-operatively. We suggest future animal studies to include both menstrual and fertility outcomes as well as long-term follow up to evaluate for risks such as ectopic pregnancy, adhesion formation and organ ischemia. Further, in the case of ectopic pregnancy, the mode of surgery should be determined prior to human studies. For example, in the case of a stable ectopic pregnancy, laparoscopy may be appropriate; whereas, in the case of a ruptured ectopic pregnancy, laparotomy may be warranted as adhesions may be more likely in these patients. In this manner, our group aims to continue to advance toward shorter, more efficient uterine transplantation, while considering safety and future goals of these patients.
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